US regulator approves limited use of malaria drugs for virus  A limited emergency-use authorization for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients .
US President Donald Trump said last week that the two drugs could be a ' gift from God , ' despite scientists warning against the dangers of overhyping unproven treatments  AFP  In a statement published Sunday , the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile -- including chloroquine and hydroxychloroquine , both being investigated as potential COVID-19 treatments .
It said the FDA had allowed them " to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19 , as appropriate , when a clinical trial is not available or feasible .
"  Trump said last week that the two drugs could be a " gift from God , " despite scientists warning against the dangers of overhyping unproven treatments .
Many researchers including Anthony Fauci , the United States ' leading infectious disease expert , have urged @ @ @ @ @ @ @ @ @ @ smaller studies .
Two US medical bodies -- the National Institutes of Health and the Biomedical Advanced Research and Development Authority -- are currently working to plan such trials .
Some in the scientific community fear Trump 's endorsement of the medicines could create shortages for patients who need them to treat lupus and rheumatoid arthritis , diseases for which they are approved .
The US has more than 140,000 novel coronavirus cases and 2,489 deaths , according to a tracker maintained by Johns Hopkins University .
